These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11713377)

  • 1. Systemic capillary leak syndrome preceding plasma cell leukaemia.
    Ghosh K; Madkaikar M; Iyer Y; Pathare A; Jijina F; Mohanty D
    Acta Haematol; 2001; 106(3):118-21. PubMed ID: 11713377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
    Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
    Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term disease-free survival in a primary plasma cell leukemia treated by VAD, autologous PBSC transplantation, and IFN-alpha.
    Büchler T; Ferra C; Domingo A; Gallardo D; Sarra J; Grańena A
    Am J Hematol; 2002 Sep; 71(1):62. PubMed ID: 12221683
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary plasma cell leukemia: a case report of successful responder to a combination chemotherapy of vincristine, doxorubicin and dexamethasone.
    Suzuki M; Kawauchi K; Sugiyama H; Yasuyama M; Watanabe H
    Acta Haematol; 1989; 82(2):95-7. PubMed ID: 2508402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
    Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR
    Bone Marrow Transplant; 2002 Apr; 29(7):577-80. PubMed ID: 11979306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rapidly progressive AL amyloidosis in a patient with relapsed multiple myeloma after achieving a complete response to tandem autologous PBSCT].
    Yagi H; Ozaki S; Sekimoto E; Shibata H; Shigekiyo T; Satake N
    Rinsho Ketsueki; 2013 Dec; 54(12):2171-6. PubMed ID: 24452148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature.
    Hovenga S; de Wolf JT; Klip H; Vellenga E
    Bone Marrow Transplant; 1997 Nov; 20(10):901-4. PubMed ID: 9404934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone.
    Christou L; Hatzimichael E; Chaidos A; Tsiara S; Bourantas KL
    Eur J Haematol; 2001 Jul; 67(1):51-3. PubMed ID: 11553267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
    Lokhorst HM; Sonneveld P; Cornelissen JJ; Joosten P; van Marwijk Kooy M; Meinema J; Nieuwenhuis HK; van Oers MH; Richel DJ; Segeren CN; Veth G; Verdonck LF; Wijermans PW
    Bone Marrow Transplant; 1999 Feb; 23(4):317-22. PubMed ID: 10100574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intensive chemotherapy in AL amyloidosis: usefulness of flow cytometric analysis of plasma cells in bone marrow.
    Matsuda M; Gono T; Shimojima Y; Sakashita K; Koike K; Ikeda S
    Amyloid; 2003 Dec; 10(4):250-6. PubMed ID: 14986484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).
    Jelinek T; Mihalyova J; Kascak M; Duras J; Popkova T; Benkova K; Richterova P; Plonkova H; Zuchnicka J; Broskevicova L; Huvarova L; Cerna L; Growkova K; Simicek M; Havel M; Gumulec J; Navratil M; Koristek Z; Paiva B; Hajek R
    Am J Hematol; 2019 Jan; 94(1):E35-E37. PubMed ID: 30370955
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF).
    Rechner I; Brito-Babapulle F; Fielden J
    Hematol J; 2003; 4(1):54-6. PubMed ID: 12692521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome.
    Pineton de Chambrun M; Gousseff M; Mauhin W; Lega JC; Lambert M; Rivière S; Dossier A; Ruivard M; Lhote F; Blaison G; Alric L; Agard C; Saadoun D; Graveleau J; Soubrier M; Lucchini-Lecomte MJ; Christides C; Bosseray A; Levesque H; Viallard JF; Tieulie N; Lovey PY; Le Moal S; Bibes B; Malizia G; Abgueguen P; Lifermann F; Ninet J; Hatron PY; Amoura Z;
    Am J Med; 2017 Oct; 130(10):1219.e19-1219.e27. PubMed ID: 28602874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resident rounds part III: plasma cell leukemia with initial cutaneous presentation.
    Fabbro SK; Kaffenberger BH
    J Drugs Dermatol; 2014 Aug; 13(8):994-5. PubMed ID: 25271340
    [No Abstract]   [Full Text] [Related]  

  • 16. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
    Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
    Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. bcr-abl-positive T-cell acute lymphoblastic leukemia associated with parvovirus B19 infection.
    Abla O; Gassas A; Stevens R; Grant R; Abdelhaleem M
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):98-9. PubMed ID: 16462583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
    Iino M; Nakajima A; Shindo H
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2441-3. PubMed ID: 19098420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.
    Sezer O; Schmid P; Shweigert M; Heider U; Eucker J; Harder H; Sinha P; Radtke H; Possinger K
    Bone Marrow Transplant; 1999 May; 23(9):967-9. PubMed ID: 10338056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.